Table 1 Multivariate linear regression analysis output for variables independently associated with IgA, IgG and IgM on day 1
Variable | B | 95% CI | p |
|---|---|---|---|
IgA | |||
Female sex | − 34.1 | − 47.5: − 20.7 | 7.0 × 10–7 |
BMI | 2.6 | 1.4: 3.8 | 1.5 × 10–5 |
White blood cell count at baseline | 1.4 | 0.7: 2.1 | 6.0 × 10–5 |
CV comorbidities | 28.6 | 11.2: 46.1 | 0.001 |
Randomized to crystalloids | 19.4 | 6.3: 32.5 | 0.004 |
Onco-haematologic disease | − 48.0 | − 87.0: − 9.1 | 0.016 |
Creatinine | − 3.5 | − 7.6: 0.6 | 0.090 |
Immunocompromised state | − 18.3 | − 40.0: 3.3 | 0.097 |
IgG | |||
Female sex | − 88.5 | − 135.5: − 41.4 | 2.4 × 10–4 |
White blood cell count at baseline | 4.2 | 1.7: 6.6 | 0.001 |
Randomized to crystalloids | 73.7 | 27.5: 120.0 | 0.002 |
BMI | 5.8 | 1.7: 10.0 | 0.006 |
Shock | − 55.1 | − 101.8: − 8.4 | 0.021 |
Liver disease | 188.5 | − 3.5: 380.4 | 0.054 |
Heart rate | − 0.9 | − 2.0: 0.3 | 0.127 |
Immunocompromised state | − 9.3 | − 79.1: 60.6 | 0.794 |
IgM | |||
Age | − 0.6 | − 0.9: − 0.2 | 0.002 |
Shock | − 14.4 | − 25.3: − 3.6 | 0.009 |
Onco-haematologic disease | − 30.1 | − 58.2: − 2.0 | 0.036 |
White blood cell count at baseline | 0.4 | − 0.1: 1.0 | 0.127 |
Mean arterial pressure | 0.2 | − 0.2: 0.5 | 0.329 |